Statement re Fundraising for Portfolio Client

FIPP
27 August 2009

                              FRONTIER IP GROUP PLC
                      ("Frontier IP Group" or "the Group")

                        Fundraising for Portfolio Client

Frontier  IP  Group,  which specialises in the commercialisation  of  university
intellectual  property, is pleased to announce that it has  successfully  closed
its  first  fundraising for a portfolio client since its flotation in  May  this
year,  raising a total of £1.1m gross.  The fundraising was completed on  behalf
of  its portfolio client, B1 Medical Limited ("B1 Medical"), which has developed
a range of innovative orthopaedic devices.

The  fundraising  attracted support from both new and existing  investors.   New
investors included Barwell plc, the Glasgow-based angel investment company,  and
RGU  Ventures Investment Fund.  Existing investors who participated included the
management team of B1 Medical as well as Scottish Enterprise Co-investment Fund,
Robert   Gordon   University,  the  University  of  Aberdeen,  Scottish   Health
Innovations Limited and Sigma Technology Management Limited.

At  the  same  time,  B1 Medical has appointed a new Chief  Executive,  Dr  Mark
Wickham.  Dr Wickham has held a number of senior management roles in the medical
device industry, most recently as Operations Director at the leading orthopaedic
research centre, Smith & Nephew Research Centre, in York.

Neil Crabb, Chairman of Frontier IP Group plc, commented,

"We  are delighted to have raised additional funds for our portfolio client,  B1
Medical.  This represents the first fundraising we have completed on behalf of a
portfolio  client since our flotation on the PLUS Market and the new funds  will
enable  B1 Medical to accelerate the development of its pioneering technologies.
We  will  continue to work together with both B1 Medical and our other portfolio
clients in order to maximise the exciting opportunities available."

Dr Wickham, Chief Executive of B1 Medical, said,

"The high growth orthopaedic sector provides an exciting opportunity for leading-
edge  new  products  that  address real clinical  needs.  This  investment  will
underpin  the next stage of the development of B1 Medical's innovative products,
in   particular  enabling  us  to  expand  the  company's  marketing  and  sales
resources."

The Directors accept responsibility for the content of this announcement.

For further information please contact:

Frontier IP Group               T: 0131 220 9444
Neil Crabb, Chairman

Biddicks                        T: 020 7448 1000
Katie Tzouliadis/ Sophie Lane

Ruegg & Co Limited              T: 020 7448 4471
Gavin Burnell/ Brett Miller




About Frontier IP Group plc
www.frontierip.co.uk

Based  in  Edinburgh,  Frontier IP specialises in the commercialisation  of  the
intellectual  property developed by universities and research  institutions.  It
establishes  partnerships with individual universities and research institutions
to assist with their spin-out activities and so helps to maximise the commercial
value of technologies emerging from their research programmes.

Frontier IP is a subsidiary of Sigma Capital Group plc, the AIM quoted, UK-based
asset management group.

About B1 Medical Limited
www.b1medical.com

B1  Medical  is  a  unique  collaboration focused on  the  commercialisation  of
intellectual  property in the field of orthopaedics from the NHS  Grampian,  the
University  of  Aberdeen and Robert Gordon University. It received  first  round
funding  in  July 2006 of £1.3m from the Sigma Technology Venture Fund  and  the
Scottish  Co-investment Fund. It has developed a range of innovative orthopaedic
devices  based on intellectual property licensed from the founding  institutions
and has an ongoing pipeline agreement giving it access to future inventions.